State Street’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79M | Sell |
336,494
-1,639
| -0.5% | -$13.6K | ﹤0.01% | 3193 |
|
|
2025
Q1 | $2.06M | Sell |
338,133
-1,580
| -0.5% | -$9.62K | ﹤0.01% | 3238 |
|
|
2024
Q4 | $2.15M | Buy |
339,713
+11,454
| +3% | +$72.4K | ﹤0.01% | 3296 |
|
|
2024
Q3 | $1.64M | Buy |
328,259
+7,053
| +2% | +$35.3K | ﹤0.01% | 3383 |
|
|
2024
Q2 | $1.96M | Buy |
321,206
+17,687
| +6% | +$108K | ﹤0.01% | 3326 |
|
|
2024
Q1 | $3.38M | Buy |
303,519
+37,869
| +14% | +$421K | ﹤0.01% | 3092 |
|
|
2023
Q4 | $2.98M | Buy |
265,650
+4,216
| +2% | +$47.3K | ﹤0.01% | 3169 |
|
|
2023
Q3 | $1.96M | Sell |
261,434
-51
| -0% | -$383 | ﹤0.01% | 3348 |
|
|
2023
Q2 | $2.31M | Buy |
+261,485
| New | +$2.31M | ﹤0.01% | 3346 |
|
|
2021
Q2 | – | Sell |
-327,151
| Closed | -$2.03M | – | 4475 |
|
|
2021
Q1 | $2.03M | Sell |
327,151
-13,900
| -4% | -$86.3K | ﹤0.01% | 3431 |
|
|
2020
Q4 | $2.54M | Buy |
341,051
+12,745
| +4% | +$95K | ﹤0.01% | 3269 |
|
|
2020
Q3 | $1.99M | Buy |
328,306
+46,438
| +16% | +$281K | ﹤0.01% | 3199 |
|
|
2020
Q2 | $2.35M | Buy |
+281,868
| New | +$2.35M | ﹤0.01% | 3121 |
|
|
2019
Q2 | – | Sell |
-167,372
| Closed | -$812K | – | 3830 |
|
|
2019
Q1 | $812K | Buy |
167,372
+5,454
| +3% | +$26.5K | ﹤0.01% | 3375 |
|
|
2018
Q4 | $1.03M | Buy |
161,918
+6,193
| +4% | +$39.5K | ﹤0.01% | 3322 |
|
|
2018
Q3 | $1.28M | Buy |
155,725
+7,400
| +5% | +$60.7K | ﹤0.01% | 3365 |
|
|
2018
Q2 | $1.55M | Buy |
+148,325
| New | +$1.55M | ﹤0.01% | 3340 |
|